Poststerone increases muscle fibre size partly similar to its metabolically parent compound, 20-hydroxyecdysone

József Csábi, Timea Rafai, Attila Hunyadi, E. Zádor

Research output: Contribution to journalArticle

Abstract

In mice, poststerone is a major in vivo metabolite of the worldwide popular anabolic food supplement 20-hydroxyecdysone (20E). Here we present the first study on this ecdysteroid in view of the in vivo anabolic effect of its parent compound, 20E in mammals. We have monitored muscle fibre type cross sectional areas (CSA) of developing rats after treatment with poststerone as we did in a previous study with 20E. The muscle mass and fibre CSAs of soleus and EDL were increased by poststerone in a muscle specific manner as by 20E but there were some differences. Notably, the CSAs of type I and type IIa fibres in the soleus were less elevated by poststerone than by 20E. However poststerone increased the CSA of each four fibre types (I, IIa, IIx, IIb) in the EDL more effectively than 20E did. Poststerone, like 20E, also increased the number of myonuclei in the EDL of both hind limbs. Overall, this shows for the first time that poststerone having steroid nucleus and no side chain of 20E has a partly overlapping effect with that of 20E.

Original languageEnglish
Pages (from-to)459-464
Number of pages6
JournalFitoterapia
Volume134
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Ecdysterone
Muscles
Ecdysteroids
Anabolic Agents
Dietary Supplements
Mammals
Extremities
Steroids
compound 20

Keywords

  • 20-hydroxyecdysone
  • Anabolic effect
  • Poststerone
  • Skeletal muscle fibre size

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Poststerone increases muscle fibre size partly similar to its metabolically parent compound, 20-hydroxyecdysone. / Csábi, József; Rafai, Timea; Hunyadi, Attila; Zádor, E.

In: Fitoterapia, Vol. 134, 01.04.2019, p. 459-464.

Research output: Contribution to journalArticle

@article{866ee0b0c91745cd8e636ecc3b778283,
title = "Poststerone increases muscle fibre size partly similar to its metabolically parent compound, 20-hydroxyecdysone",
abstract = "In mice, poststerone is a major in vivo metabolite of the worldwide popular anabolic food supplement 20-hydroxyecdysone (20E). Here we present the first study on this ecdysteroid in view of the in vivo anabolic effect of its parent compound, 20E in mammals. We have monitored muscle fibre type cross sectional areas (CSA) of developing rats after treatment with poststerone as we did in a previous study with 20E. The muscle mass and fibre CSAs of soleus and EDL were increased by poststerone in a muscle specific manner as by 20E but there were some differences. Notably, the CSAs of type I and type IIa fibres in the soleus were less elevated by poststerone than by 20E. However poststerone increased the CSA of each four fibre types (I, IIa, IIx, IIb) in the EDL more effectively than 20E did. Poststerone, like 20E, also increased the number of myonuclei in the EDL of both hind limbs. Overall, this shows for the first time that poststerone having steroid nucleus and no side chain of 20E has a partly overlapping effect with that of 20E.",
keywords = "20-hydroxyecdysone, Anabolic effect, Poststerone, Skeletal muscle fibre size",
author = "J{\'o}zsef Cs{\'a}bi and Timea Rafai and Attila Hunyadi and E. Z{\'a}dor",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.fitote.2019.03.017",
language = "English",
volume = "134",
pages = "459--464",
journal = "Fitoterapia",
issn = "0367-326X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Poststerone increases muscle fibre size partly similar to its metabolically parent compound, 20-hydroxyecdysone

AU - Csábi, József

AU - Rafai, Timea

AU - Hunyadi, Attila

AU - Zádor, E.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - In mice, poststerone is a major in vivo metabolite of the worldwide popular anabolic food supplement 20-hydroxyecdysone (20E). Here we present the first study on this ecdysteroid in view of the in vivo anabolic effect of its parent compound, 20E in mammals. We have monitored muscle fibre type cross sectional areas (CSA) of developing rats after treatment with poststerone as we did in a previous study with 20E. The muscle mass and fibre CSAs of soleus and EDL were increased by poststerone in a muscle specific manner as by 20E but there were some differences. Notably, the CSAs of type I and type IIa fibres in the soleus were less elevated by poststerone than by 20E. However poststerone increased the CSA of each four fibre types (I, IIa, IIx, IIb) in the EDL more effectively than 20E did. Poststerone, like 20E, also increased the number of myonuclei in the EDL of both hind limbs. Overall, this shows for the first time that poststerone having steroid nucleus and no side chain of 20E has a partly overlapping effect with that of 20E.

AB - In mice, poststerone is a major in vivo metabolite of the worldwide popular anabolic food supplement 20-hydroxyecdysone (20E). Here we present the first study on this ecdysteroid in view of the in vivo anabolic effect of its parent compound, 20E in mammals. We have monitored muscle fibre type cross sectional areas (CSA) of developing rats after treatment with poststerone as we did in a previous study with 20E. The muscle mass and fibre CSAs of soleus and EDL were increased by poststerone in a muscle specific manner as by 20E but there were some differences. Notably, the CSAs of type I and type IIa fibres in the soleus were less elevated by poststerone than by 20E. However poststerone increased the CSA of each four fibre types (I, IIa, IIx, IIb) in the EDL more effectively than 20E did. Poststerone, like 20E, also increased the number of myonuclei in the EDL of both hind limbs. Overall, this shows for the first time that poststerone having steroid nucleus and no side chain of 20E has a partly overlapping effect with that of 20E.

KW - 20-hydroxyecdysone

KW - Anabolic effect

KW - Poststerone

KW - Skeletal muscle fibre size

UR - http://www.scopus.com/inward/record.url?scp=85063472222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063472222&partnerID=8YFLogxK

U2 - 10.1016/j.fitote.2019.03.017

DO - 10.1016/j.fitote.2019.03.017

M3 - Article

VL - 134

SP - 459

EP - 464

JO - Fitoterapia

JF - Fitoterapia

SN - 0367-326X

ER -